Related Experiment Video
Updated: Mar 7, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Pathophysiology and treatment of atherosclerosis : Current view and future perspective on lipoprotein modification
S C Bergheanu1,2, M C Bodde3, J W Jukema4
1Centre for Human Drug Research, Leiden, The Netherlands.
Abstract:
Recent years have brought a significant amount of new results in the field of atherosclerosis. A better understanding of the role of different lipoprotein particles in the formation of atherosclerotic plaques is now possible. Recent cardiovascular clinical trials have also shed more light upon the efficacy and safety of novel compounds targeting the main pathways of atherosclerosis and its cardiovascular complications.In this review, we first provide a background consisting of the current understanding of the pathophysiology and treatment of atherosclerotic disease, followed by our future perspectives on several novel classes of drugs that target atherosclerosis. The focus of this update is on the pathophysiology and medical interventions of low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and lipoprotein(a) (Lp(a)).
Insights
This review covers new findings in atherosclerosis, focusing on how lipoprotein particles like LDL-C, HDL-C, TG, and Lp(a) contribute to plaque formation and how new drugs target these pathways.
Area of Science:
- Cardiovascular Medicine
- Lipid Metabolism
- Pharmacology
Background:
- Atherosclerosis pathogenesis and current treatment strategies are evolving.
- Understanding lipoprotein particle roles in plaque formation is improving.
- Recent clinical trials offer insights into novel therapeutic agents.
Purpose of the Study:
- To review current knowledge on atherosclerosis pathophysiology and treatment.
- To discuss emerging drug classes targeting atherosclerosis.
- To focus on key lipid targets: LDL-C, HDL-C, TG, and Lp(a).
Main Methods:
- Literature review of recent findings in atherosclerosis.
- Analysis of cardiovascular clinical trial data.
- Synthesis of current understanding and future perspectives on novel therapies.
Main Results:
- Enhanced understanding of lipoprotein particle involvement in atherosclerotic plaque development.
- Evaluation of the efficacy and safety of novel compounds targeting atherosclerosis pathways.
- Identification of key lipid targets for therapeutic intervention.
Conclusions:
- Novel therapeutic strategies targeting specific lipoproteins show promise for managing atherosclerosis.
- Continued research into lipid metabolism and cardiovascular complications is crucial.
- Personalized medicine approaches may optimize treatment for atherosclerotic disease.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis I: Introduction
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care

